Oruka Therapeutics, Inc. (ORKA)
32.13
-0.51
(-1.56%)
USD |
NASDAQ |
Feb 13, 15:41
Oruka Therapeutics Free Cash Flow : -84.60M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CDT Equity, Inc. | -15.13M |
| LENZ Therapeutics, Inc. | -46.16M |
| Liminatus Pharma, Inc. | -10.38M |
| Maze Therapeutics, Inc. | -108.03M |
| MapLight Therapeutics, Inc. | -109.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.60M |
| Cash from Investing (Quarterly) | -122.45M |
| Cash from Financing (Quarterly) | 169.91M |
| Free Cash Flow Per Share (Quarterly) | -0.4925 |
| Free Cash Flow to Equity (Quarterly) | -21.29M |
| Free Cash Flow to Firm (Quarterly) | -21.70M |
| Free Cash Flow Yield | -6.27% |